Westend S.A.
CIK 1283968 · last filed 2024-03-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.52B
Companies
6
Total Filings
11
Lifetime Open-Market Net
-$4.81B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAVA | Director | 26,507,990 | $82.24 | $2.18B | -$795.00M | 2 | 2024-03-25 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 8,589,064 | $15.70 | $134.85M | $1.36M | 1 | 2023-02-28 |
| SRRK | 10%+ Owner | 8,850,005 | $52.33 | $463.12M | $6.08M | 1 | 2022-10-07 |
| WTW | 10%+ Owner | 14,818,300 | $261.50 | $3.87B | -$4.08B | 5 | 2018-08-16 |
| LXRX | Director | 2,130,717 | $2.22 | $4.73M | $50.03M | 1 | 2018-06-04 |
| Ceres, Inc. (CERE) Delisted | Director | 4,192,167 | $44.96 | $188.48M | $0 | 1 | 2012-11-13 |
Recent Filings · Page 2 of 2
11 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Showing 11–11 of 11
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.